Silver Nitrate vs. Triamcinolone for Treatment of Hypergranulation Tissue

A Comparative Study of Silver Nitrate, Triamcinolone, and Their Successive Combined Use on Hypergranulation Tissue in Traumatic Wounds: A Randomized Control Trial

This randomized controlled trial aims to compare the efficacy of silver nitrate, triamcinolone, and a successive use of both treatments in managing hypergranulation tissue in traumatic wounds. Conducted over a four-year period at UPMC Mercy, the study will involve patients presenting with hypergranulation tissue. Participants will be randomly assigned to receive either topical silver nitrate, topical triamcinolone, or a combination of the two in succession. The study will assess treatment outcomes based on the reduction or resolution of hypergranulation tissue, with the goal of identifying the most effective therapeutic approach. This research will provide valuable insights into optimizing treatment strategies for hypergranulation tissue in traumatic wounds.

Inclusion Criteria:

• Patients must be 18 years or older.
• Patients must be admitted to the institution with non-infected, traumatic wounds exhibiting hypergranulation tissue.
• Patients must provide consent to participate in the study.
• Eligible wounds include superficial or partial-thickness wounds.
• Wounds will be categorized based on size and depth, with variations controlled for in the statistical analysis.

Exclusion Criteria:

• Patients with known allergies or contraindications to silver nitrate or triamcinolone.
• Patients with wounds that do not exhibit hypergranulation tissue.
• Patients with wounds not primarily due to traumatic injury (e.g., surgical wounds, pressure ulcers).
• Full-thickness, infected, or complex wounds will be excluded, as these may require different management strategies.